Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension

NCT02238535 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT02238535
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238535 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2014
Completion date
October 31, 2016
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

residual pulmonary hypertension